DOVE, created by Purdue researchers, captures structural and energetic features...
DOVE, created by Purdue researchers, captures structural and energetic features of the interface of a protein docking model with a 3D box and judges if the model is more likely to be correct or incorrect using 3D convolutional neural network.
Source: Purdue University

Deep learning, 3D tech create better drugs

Proteins are often called the working molecules of the human body. A typical body has more than 20,000 different types of proteins, each of which are involved in many functions essential to human life. Now, Purdue University researchers have designed a novel approach to use deep learning to better understand how proteins interact in the body – paving the way to producing accurate structure models of protein interactions involved in various diseases and to design better drugs that specifically target protein interactions.

“To understand molecular mechanisms of functions of protein complexes, biologists have been using experimental methods such as X-rays and microscopes, but they are time- and resource-intensive efforts,” said Daisuke Kihara, a professor of biological sciences and computer science in Purdue’s College of Science, who leads the research team. “Bioinformatics researchers in our lab and other institutions have been developing computational methods for modeling protein complexes. One big challenge is that a computational method usually generates thousands of models, and choosing the correct one or ranking the models can be difficult.”

Kihara and his team developed a system called DOVE, DOcking decoy selection with Voxel-based deep neural network, which applies deep learning principles to virtual models of protein interactions. DOVE scans the protein-protein interface of a model and then uses deep learning model principles to distinguish and capture structural features of correct and incorrect models.

“Our work represents a major advancement in the field of bioinformatics,” said Xiao Wang, a graduate student and member of the research team. “This may be the first time researchers have successfully used deep learning and 3D features to quickly understand the effectiveness of certain protein models. Then, this information can be used in the creation of targeted drugs to block certain protein-protein interactions.”

Subscribe to our newsletter

Related articles

Deep learning helps visualize X-ray data in 3D

Deep learning helps visualize X-ray data in 3D

Scientists have leveraged artificial intelligence to train computers to keep up with the massive amounts of X-ray data taken at the Advanced Photon Source.

Using AI to find new uses for existing medications

Using AI to find new uses for existing medications

Scientists have developed a machine learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed.

Deep learning assists in detecting malignant lung cancers

Deep learning assists in detecting malignant lung cancers

Radiologists assisted by deep learning based software were better able to detect malignant lung cancers on chest X-rays.

'Deepfaking the mind' to improve brain-computer interfaces

'Deepfaking the mind' to improve brain-computer interfaces

Researchers are using generative adversarial networks to improve brain-computer interfaces for people with disabilities.

Researchers psychoanalyse artificial intelligence

Researchers psychoanalyse artificial intelligence

We can run tests and experiments, but we cannot always predict and understand why AI does what it does.

The progress and risks of artificial intelligence

The progress and risks of artificial intelligence

Artificial intelligence has reached a critical turning point in its evolution, according to an international panel of experts.

AI identifies drug combinations to fight COVID-19

AI identifies drug combinations to fight COVID-19

Data scientists have used deep learning to identify the right synergistic drug combinations for the rapidly spreading SARS-CoV-2.

AI screens and diagnoses glaucoma

AI screens and diagnoses glaucoma

Scientists have developed a novel method that uses artificial intelligence to screen for glaucoma.

AI and simulation tools to fight COVID-19

AI and simulation tools to fight COVID-19

Argonne, industry and academia collaborate to bring innovative AI and simulation tools to the COVID-19 battlefront.

Popular articles

Subscribe to Newsletter